Micron Technology Inc. (NASDAQ:MU): Sterne Agee thinks that the company is the only supplier with DRAM available in any material quantities, and the firm believes that overall DRAM contract trends will continue to be positive into the June quarter. Sterne Agee keeps its Buy rating and $12 price target on the stock.
Newcastle Investment Corp. (NYSE:NCT): UBS has stated that Newcastle Investment weakness is a result of concerns about higher prepayments and the impact on the MSR portfolio and the newly spun New Residential. The analyst views Newcastle’s MSR portfolio as being in the position for potential prepayments, and it believes that shares can outperform. The firm gives the shares a Buy rating and a $14 price target.
The Children’s Place Retail Stores, Inc. (NASDAQ:PLCE): According to Citigroup, Children’s Place’s 2013 guidance appears to be conservative, and shares are attractively valued at current levels. The firm has decided to keep its Buy rating and $58 price target on the stock after the company’s Q4 results.
Pioneer Natural Resources Co. (NYSE:PXD): SunTrust has called Pioneer Natural its new Top Pick, and it thinks that shares have underperformed as a result of concerns regarding its financing needs. The analyst believes that its revolver capacity and net debt to EBITDA through 2014 will continue to be unchanged and views its Midland Basin assets are undervalued. The firm gives the shares a Buy rating and a $6.50 price target.
Raptor Pharmaceuticals Corp. (NASDAQ:RPTP): Oppenheimer thinks that the April 30 PDUFA date for Raptor’s Procysbi treatment for Nephropathic Cystinosis will provide a catalyst for the stock. The firm views this disclosure of pricing for the drug within one to two months after the PDUFA date as likely to also provide a catalyst for the stock, and it reiterates its $11 price target and Outperform rating on the shares.
Don’t Miss: What Happens in an Internet Minute?